Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 DegradationHanshu Liu, Hongxia Liang, Yingqiu Qi et al.|ACS Nano|2025Cited by 18
LRG1-Targeted Nintedanib Delivery for Enhanced Renal Fibrosis MitigationYana Zhang, Yingqiu Qi, Linyao Fan et al.|Nano Letters|2024Cited by 14
LRG1-Targeted Camptothecin Nanomicelles with Simultaneous Delivery of Olaparib for Enhanced Colorectal Cancer ChemotherapyLin Du, Gang Wu, Huan Min et al.|Nano Letters|2025Cited by 12
Targeted degradation of LRG1 to attenuate renal fibrosisLinyao Fan, Huan Min, Yingqiu Qi et al.|Asian Journal of Pharmaceutical Sciences|2024Cited by 9
SAT-049 Harnessing antioxidant nano-chimeras for combining targeted transforming growth factor β receptor I degradation and transforming growth factor β reduction to attenuate liver fibrosisHanshu Liu, Longdi Wang, Hongxia Liang et al.|Journal of Hepatology|2025Cited by 0